ATHYMIL, created in 1967 (Netherlands), from 402 sister brands and 17477 competing brands. The ATHYMIL brand is owned by Merck & Co, a company listed in New York. ATHYMIL belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Merck & Co
(ATHYMIL)
over 5 years*
USD 219.35